Project Details
Abstract
In order to survive, cells must translate and integrate the signals they receive from their environment. Many intracellular enzyme cascades are activated concomitantly in the cell, and they must potentiate or antagonize each other to implement physiologically relevant outcomes. Kinases, for example, can inhibit each other by direct phosphorylation of negative regulatory residues. We have recently discovered a new paradigm of kinase regulation and pathway cross-talk mediated by protein:protein interaction, in which the regulatory domain of a modular kinase (the Ras effector Raf-1) binds to and inhibits the catalytic domain of another kinase (the RhoA effector Rok-a). Importantly, this interaction is crucial for the developments of Ras-driven epidermal tumors. We now propose to obtain detailed structural information on this interaction, with the aim of informing the design of inhibitors that would disrupt it.
| Status | Finished |
|---|---|
| Effective start/end date | 1/11/10 → 31/10/15 |
Keywords
- Raf-1
- Rok-alpha
- Protein:Protein Interaction
- Kinase Inhibition
- Pathway Cross-Talk
- Ras and Rho signaling
Publications
- 2 Article
-
Deciphering the RAS/ERK pathway in vivo
Dorard, C., Vucak, G. & Baccarini, M., 8 Feb 2017, In: Biochemical Society Transactions. 45, 1, p. 27-36 10 p.Publications: Contribution to journal › Article › Peer Reviewed
-
RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα
Varga, A., Ehrenreiter, K., Aschenbrenner, B., Kocieniewski, P., Kochanczyk, M., Lipniacki, T. & Baccarini, M. (Corresponding author), 7 Mar 2017, In: Science Signaling. 10, 469, 11 p., eaai8482.Publications: Contribution to journal › Article › Peer Reviewed